Application of metagenomic next-generation sequencing in patients with infective endocarditis

被引:7
作者
Li, Shao-Lin [1 ]
Zhao, Xi [1 ]
Tao, Jun-Zhong [1 ]
Yue, Zhen-Zhen [1 ]
Zhao, Xiao-Yan [1 ]
机构
[1] Zhengzhou Univ, Cardiovasc Ctr, Dept Cardiol, Henan Key Lab Hereditary Cardiovasc Dis,Affiliated, Zhengzhou, Henan, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2023年 / 13卷
关键词
metagenomic next-generation sequencing; infective endocarditis; culture-negative; culture-positive; antibiotic regimen; CULTURE-NEGATIVE ENDOCARDITIS; CHALLENGES; DIAGNOSIS;
D O I
10.3389/fcimb.2023.1107170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesMetagenomic next-generation sequencing (mNGS) technology is helpful for the early diagnosis of infective endocarditis, especially culture-negative infective endocarditis, which may guide clinical treatment. The purpose of this study was to compare the presence of culture-negative infective endocarditis pathogens versus culture-positive ones, and whether mNGS test results could influence treatment regimens for patients with routine culture-negative infective endocarditis. MethodsThe present study enrolled patients diagnosed with infective endocarditis and tested for mNGS in the First Affiliated Hospital of Zhengzhou University from February 2019 to February 2022 continuously. According to the culture results, patients were divided into culture-negative group (Group CN, n=18) and culture-positive group (Group CP, n=32). The baseline characteristics, clinical data, pathogens, 30 day mortality and treatment regimen of 50 patients with infective endocarditis were recorded and analyzed. ResultsExcept for higher levels of PCT in the Group CN [0.33 (0.16-2.74) ng/ml vs. 0.23 (0.12-0.49) ng/ml, P=0.042], there were no significant differences in the basic clinical data and laboratory examinations between the two groups (all P>0.05). The aortic valve and mitral valve were the most involved valves in patients with infective endocarditis (aortic valve involved: Group CN 10, Group CP 16; mitral valve involved: Group CN 8, Group CP 21; P>0.05) while 9 patients had multiple valves involved (Group CN 2, Group CP 7; P>0.05). The detection rate of non-streptococci infections in the Group CN was significantly higher than that in the Group CP (9/18 vs. 3/32, P=0.004). There was no significant difference in patients with heart failure hospitalization and all-cause death at 30 days after discharge (3 in Group CN vs. 4 in Group CP, P>0.05). It is worth noting that 10 patients with culture-negative infective endocarditis had their antibiotic regimen optimized after the blood mNGS. ConclusionsCulture-negative infective endocarditis should be tested for mNGS for early diagnosis and to guide clinical antibiotic regimen.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] Clinical Application of Metagenomic Next-Generation Sequencing in Sepsis Patients with Early Antibiotic Treatment
    Chen, Yongru
    Chen, Chongyue
    Chen, Wei
    Gai, Wei
    Zheng, Yafeng
    Guo, Yuxin
    Wang, Zhaoning
    Chen, Yongsong
    Cai, Zhiming
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 4695 - 4706
  • [12] Metagenomic next-generation sequencing for the diagnosis of neurobrucellosis
    Li, Wen
    He, Ying
    Li, Yanyan
    Li, Xiaona
    Bian, Ting
    Liu, Tingting
    Liu, Xuedong
    Jiang, Wen
    FUTURE MICROBIOLOGY, 2024, 19 (06) : 509 - 518
  • [13] Application of metagenomic next-generation sequencing in the detection of pathogens in spinal infections
    Wang, Guanzhong
    Long, Jiang
    Zhuang, Yong
    Leng, Xue
    Zhang, Yaqing
    Liu, Libangxi
    Fu, Jiawei
    Chen, Yu
    Li, Changqing
    Zhou, Yue
    Huang, Bo
    Feng, Chencheng
    SPINE JOURNAL, 2023, 23 (06) : 859 - 867
  • [14] Clinical application of metagenomic next-generation sequencing in tuberculosis diagnosis
    Liu, Ying
    Wang, Huifen
    Li, Yaoguang
    Yu, Zujiang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 12
  • [15] Application of Metagenomic Next-Generation Sequencing in Mycobacterium tuberculosis Infection
    Li, Yaoguang
    Jiao, Mengfan
    Liu, Ying
    Ren, Zhigang
    Li, Ang
    FRONTIERS IN MEDICINE, 2022, 9
  • [16] Application of metagenomic next-generation sequencing in optimizing the diagnosis of ascitic infection in patients with liver cirrhosis
    Shi, Pei
    Liu, Juan
    Liang, An
    Zhu, Wentao
    Fu, Jiwei
    Wu, Xincheng
    Peng, Yuchen
    Yuan, Songsong
    Wu, Xiaoping
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [17] The clinical application of metagenomic next-generation sequencing in immunocompromised patients with severe respiratory infections in the ICU
    Zhao, Junjie
    Sun, Yong
    Tang, Jing
    Guo, Kai
    Wang, Kaiyu
    Zhuge, Jiancheng
    Fang, Honglong
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [18] Use of Plasma Metagenomic Next-generation Sequencing for Pathogen Identification in Pediatric Endocarditis
    To, Rachel K.
    Ramchandar, Nanda
    Gupta, Aamisha
    Pong, Alice
    Cannavino, Christopher
    Foley, Jennifer
    Farnaes, Lauge
    Coufal, Nicole G.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (05) : 486 - 488
  • [19] Clinical Application of Metagenomic Next-Generation Sequencing for Suspected Infections in Patients With Primary Immunodeficiency Disease
    Tang, Wenjing
    Zhang, Yu
    Luo, Chong
    Zhou, Lina
    Zhang, Zhiyong
    Tang, Xuemei
    Zhao, Xiaodong
    An, Yunfei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [20] Metagenomic next-generation sequencing for pulmonary infections diagnosis in patients with diabetes
    Siqin Zhang
    Jing Ou
    Yuxue Tan
    Bin Yang
    Yaoyao Wu
    Lin Liu
    BMC Pulmonary Medicine, 23